Dr. Anna Balance review: the formula behind the wild-yam description

The final ingredients are different from the source material

The seller describes a laboratory conversion when explaining the wild-yam origin of progesterone. The declaration names progesterone and pregnenolone alongside Tripeptide-29, moisturizing ingredients and other materials. Lavender and lemongrass ingredients are also listed. A summary that calls the product only wild-yam skincare would omit information relevant to a reader’s assessment. Source 1

The botanical source does not make progesterone another name for estriol. Our estriol and estradiol chapter illustrates why exact hormone identity matters, although it is not a clinical comparison of this Balance formula. Evidence about one named substance or a different preparation should not be transferred to another simply because both are applied to skin.

Keep a copy of the complete declaration, including the base, when seeking further information. A highlighted peptide and a hormone-containing ingredient list can coexist; one does not cancel the other. The review has not authenticated a delivered label, and a future label should be checked against the specific product being considered rather than an old promotional description.

The record does not supply a verified delivered dose

We did not establish the concentration of progesterone or pregnenolone, a measured amount per pump or independently appraised absorption data for the marketed cream. Those details would be needed to make meaningful exposure comparisons. Package size and a seller’s estimated number of uses do not establish the amount reaching a person’s circulation. Source 1

The manufacturer says the product may influence hormones and recommends consultation with a healthcare provider. That caution is relevant alongside the skin-smoothness promise. The safety chapter explains why existing care and individual history belong in a professional discussion, without asserting that different topical hormone preparations share the same exposure or evidence.

This article does not recommend applying the product to a particular body site, following a cycle or combining it with prescribed treatment. Public records cannot supply the individualized assessment behind those decisions. A useful next request asks for documented concentrations and the exact preparation, rather than treating an attractive application-count estimate as clinical guidance.

Skincare positioning does not settle approval status

FDA describes intended use and claims as central to the distinction between cosmetics and drugs. A product’s location in a skincare shop is not proof of approval for a hormonal effect or a guarantee that systemic effects cannot occur. This review did not verify FDA approval of the finished Balance preparation. Source 2

That statement is intentionally about the reviewed product. It is not a claim that all preparations containing progesterone or pregnenolone have the same regulatory status, indication or evidence. The research guide keeps a study connected to its actual formulation, dose and outcome before applying it to a current purchase.

Testimonials and an ingredient’s familiar name cannot replace that connection. A report of feeling better after use does not independently establish causation, and a botanical-origin explanation does not establish a safe or effective exposure level. The available retail page is useful for identifying questions, while leaving those clinical conclusions unresolved.

The order interval belongs to the commercial offer

The $54.95 amount was presented for one-time purchase. The $47.26 options involved delivery every two or three months. Those intervals specify an order arrangement, not a medically established schedule for using a hormone-containing preparation. They should not be copied into a review as an instruction about how often a person should apply or replace the cream. Source 1

A $6.99 priority option appeared separately. It concerns order handling rather than a verified promise of clinician access or answers to medical questions. We did not complete checkout, test a renewal cancellation or establish the final taxes and delivery charges for an address. A lower recurring price therefore needs to stay beside its continuing billing conditions.

The product page described US-only availability and promoted a sixty-day guarantee. Complete eligibility conditions were not independently inspected for this review, so we do not promise reimbursement after opening or repayment of postage. Ask which orders qualify, when the period begins and what happens after a recurring shipment has been charged before relying on the headline.

Skin tolerance is only one part of the decision

AAD’s advice on trying skincare concerns identifying a local reaction; it cannot establish whether hormonal exposure is suitable. The absence of immediate discomfort would not prove that systemic absorption is absent. Likewise, a concern about fragrance ingredients does not answer the separate question of progesterone or pregnenolone exposure. Source 3

The routine chapter encourages keeping proposed additions visible alongside existing products. For Balance, that record would include the full declaration, concentration information if supplied, the reason for considering it and any current hormone treatment. The public page cannot determine what a clinician would recommend after reviewing that context.

The useful conclusion is a set of identified facts and limits: the formula names hormones, the reviewed concentration and absorption information is incomplete, and the one-time and recurring prices describe different purchases. No firsthand experience, clinical equivalence to estriol or individual suitability is established by this editorial review.